失期
- 网络fail
![失期](../cache/1413676.jpg)
-
[be overdue schedule time] 超过了限定的日期;误期
-
会天大雨,道不通,度已失期。--《史记.陈涉世家》
-
失代偿期肝硬化肝内阳性结石CT分析
The Decompensated Hepato-Cirrhosis and Intrahepatic-Duct Stones : CT Analysis
-
CT观察失代偿期肝硬化肾脏病变
CT Observation of Renal Disease with Decompensated Cirrhosis
-
测定了35例肝硬化失代偿期患者血清PⅢP水平,并与40例正常人对照。
Serum procollagen peptide ( P III P ) concentrations was measured in 40 healthy adults ( control group ) and 35 patients with cirrhosis .
-
在乙肝肝硬化代偿期组和乙肝肝硬化失代偿期组之间有统计学差异(P0.05)。
In hepatitis B liver cirrhosis group , and decompensated liver cirrhosis were significantly different between groups ( P 0.05 ) .
-
目的:探讨失代偿期肝硬化(decompensatedcirrhosis,DCC)肾脏病变的CT表现和临床意义。
Purpose : To explore CT changes and clinical significance of renal disease with decompensated cirrhosis ( DCC ) .
-
PCⅢ在乙肝肝硬化代偿期组最高,其次为慢性乙型肝炎和急性乙型肝炎,乙肝肝硬化失代偿期组为最低。
PC ⅲ in hepatitis B liver cirrhosis was the highest , followed by chronic hepatitis B and acute hepatitis , decompensated liver cirrhosis group was the lowest .
-
乙型肝炎失代偿期肝硬化患者血清内毒素、IL-12、IL-18水平的检测及其意义
Serum levels of endotoxin , IL-12 and IL-18 in patients with type B hepatitis-related decompensate cirrhosis
-
肝硬化失代偿期患者腹水、胸水及血液中16SRRNA基因检测
Detection of 16S rRNA gene in ascites , pleural fluid and blood of patients with cirrhosis
-
肝硬化组与正常对照组比较:失代偿期组红细胞压积、全血高切粘度、全血低切粘度明显降低(P0.05);
The high-shear and low-shear BV and hematocrit ( HCT ) were significantly lower in decompensated cirrhosis group than those in the control group ( P0.05 ) .
-
Child-Pugh分级对失代偿期肝硬化预后的评估
Child-Pugh 's Score in Prediction of Prognosis of Patients with Decompensated Liver Cirrhosis
-
在LC组中,代偿期患者的D-dimer血浆含量明显低于失代偿期(P<0.01);
In LC group , D-dimer content of compensatory stage patients was significantly lower than that of decompensatory stage ( P < 0.01 ) .
-
结果肝硬化患者血、尿NAG水平明显高于正常对照,失代偿期明显高于代偿期。
Results The results indicated that the NAG levels of patients with liver cirrhosis were higher than those of controls .
-
材料与方法取68例肝脏CT灌注扫描,其中29例正常对照者,22例代偿期肝硬化患者,17例失代偿期肝硬化患者。
Material and Method : Dynamic contrast-enhanced single-location sequences CT scans of the liver were obtained in 68 individuals who included 29 control subjects , 22 patients with compensated cirrhosis and 17 patients with decompensated cirrhosis proven by clinical .
-
结论MELD模型能准确预测肝硬化失代偿期患者短期的临床预后,而Child&Pugh分级也可准确预测失代偿期肝硬化患者3个月的病死率。
Conclusion Both MELD and Child-Pugh scores can accurately predict the short-term prognosis of patients with decompensated liver cirrhosis .
-
慢性肾功能不全失代偿期患者与尿毒症期患者比较,前者Hb较高(P<0.01);
Hb in the patients of chronic renal insufficiency in the phase of decompensation was higher than that in the phase of urinemia ( P < 0.01 ) ;
-
肝硬变失代偿期时若血清EPO水平较前显著升高,应考虑HRS发生的可能或将要发生HRS。
In the period of failure compensation of liver cirrhosis , if the serum EPO level has a remarkably increase , the possibility of HRS should be considered .
-
目的了解前列腺素E1(PGE1)对慢性肾功不全(CRF)失代偿期患者肾动脉血流动力学的影响。
AIM To observe the effect of prostaglandin-E 1 ( PGE 1 ) on the kinetic of renal arterial blood flow in chronic renal failure ( CRF ) .
-
方法应用MELD模型公式及Child&Pugh分级对110例住院治疗的失代偿期肝硬化患者进行评分及分级,同时了解其3个月内的病死率。
Methods 110 patients with decompensated liver cirrhosis were graded with MELD formula and with Child-Pugh . The death rate was observed within three months .
-
CHE在乙肝肝硬化失代偿期组明显下降,且与其它三组之间的差异有统计学意义(P0.005)。
CHE in decompensated liver cirrhosis was significantly lower , and with the other three groups was statistically significant difference between ( P 0.005 ) . 6 .
-
结果:1、HA在慢性乙型肝炎、乙肝肝硬化代偿期、乙肝肝硬化失代偿期逐渐升高,在乙肝肝硬化失代偿期与慢性乙型肝炎之间有统计学差异(P0.001)。
HA in patients with chronic hepatitis B , hepatitis B liver cirrhosis , decompensated cirrhosis gradually increased in decompensated liver cirrhosis and chronic hepatitis B. There were significant differences between the ( P 0.001 ) .
-
肝硬化代偿期和失代偿期患者GPDA水平与对照组无显著差异(P>005);
The levels of GPDA of hepatocirrhosis patients with / without compensation and those of control group had no significant difference ( P > 0.05 ) .
-
结果:肝硬化失代偿期诱发MOF的主要因素老年组为感染,非老年组为出血,且老年组MOF的发生率、发生衰竭脏器的数目、病死率均高于非老年组。
Results : Infection is a primary factor induced MOF in the group A.But hemorrhage is a primary factor in the group B ; there were higher occurrence of MOF and higher morbidity .
-
终末期肝病模型(MELD)对重型肝炎预后评价研究失代偿期肝硬化患者的MELD评分与预后分析
Evaluation Studies of MELD to Asses the Prognosis of Patients with Severe Hepatitis ; Analysis of Model for End-stage Liver Disease Score and Prognosis on Patients with Decompensated Liver Cirrhosis
-
结论:天门冬氨酸氨基转移酶、球蛋白、HBV-DNA、自发性腹膜炎、肝性脑病、食管胃底静脉曲张破裂出血是影响肝硬化失代偿期患者预后的重要因素。
Conclusion : The factors which were related to the prognosis of the patients with decompensate hepatic cirrhosis were aspartate amino transferase , globulin , HBV-DNA , spontaneous peritonitis , hepatic encephalopathy and gastroesophageal variceal bleeding .
-
方法:设正常对照、慢性肾功能不全失代偿期患者及慢性肾功能衰竭(CRF)患者各30例。
Methods : Sixty patients with CRF ( 30 patients with uncompensated chronic renal dysfunction and the other 30 patients with chronic renal failure ) were included in the study . Thirty healthy volunteer were chosen as normal control .
-
应用OKT系列单克隆抗体,通过间接免疫荧光法,对25例肝硬化失代偿期患者及30例正常人外周血T细胞亚群进行检测。
With OKT monoclonal antibodies , the T cell subsets in peripheral blood of 25 cases of liver cirrhosis and 30 normal controls were detected by indirect immunofluorescence technique .
-
在这四种评分中,MELD-Na是预测失代偿期肝硬化患者预后较好的模型。
In these four models , MELD-Na is better prognostic model in patients with decompensated cirrhosis .
-
失代偿期组中上述各指标均为最高,尿Col-Ⅳ和LN可以反映肾小球及肾小管间质的损害程度;
Both Col-IV and LN took part in the pathological mechanism of the glomeruloselerosis : 2 . Different indexes in the failure compensation phase group were the highest , urinary Col-IV LN can reflect the lesion of the glomerulus and the renal tubule interstitial ;
-
目的:研究终末期肝病模型(MELD)与Child-Turcotte-Pugh(CTP)评分系统和肝硬化失代偿期患者短期(3个月)预后的关系。
Objective : To investigate the relationship between the model for end-stage liver disease ( MELD ) and Child-Turcotte-Pugh ( CTP ) scoring , and the prognosis of patients with decompensated liver cirrhosis .
-
目的探讨脉冲组织多普勒(PW-TDI)评价肝硬化失代偿期右心功能的临床价值。
Objective To investigate the value of PW-TDI for estimating right ventricular function in the patients with hepatic cirrhosis .